Cargando…
Tapinarof Cream 1%: First Approval
Tapinarof cream 1% (VTAMA(®)) is an aryl hydrocarbon receptor (AhR) agonist that is being developed by Dermavant Sciences Inc. (a subsidiary of Roivant Sciences Inc.) as a once-daily topical treatment for plaque psoriasis and atopic dermatitis. AhR is a ligand-dependent transcription factor that has...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427914/ https://www.ncbi.nlm.nih.gov/pubmed/35939180 http://dx.doi.org/10.1007/s40265-022-01748-6 |